Patient Monitoring & Vital Signs

Arche Healthcare is an award-winning population health management company specializing in proactive diabetic skin health and lower extremity amputation prevention (LEAP). The company develops innovative diagnostic tools and protocols designed to assess skin integrity and all elements of diabetic peripheral neuropathy—including autonomic, sensory, motor, and vascular components—to identify patient risk for diabetic foot ulcers before they develop. Arche's comprehensive offering includes objective diagnostic assessment tools, protocol utilization frameworks, outcomes-based performance analytics, and utilization/outcomes metric reporting. The flagship Arche LEAP Vitals+® protocol is architected on Population Health Management (PHM) principles and functions as a check-the-box solution for MIPS Improvement Activities, helping healthcare organizations reduce human and financial costs associated with diabetic foot complications and amputations. The company has received recognition from the Validation Institute for health value outcomes. Arche serves podiatric practices, health systems, and population health organizations focused on preventing diabetic foot ulcers and supporting health equity in underserved communities.

EUROIMMUN US, a subsidiary of the global leader EUROIMMUN Medizinische Labordiagnostika AG, is a manufacturer of in vitro diagnostic reagents and automation systems for clinical laboratory testing. The company specializes in immunodiagnostic assays and automated laboratory analyzers serving clinical laboratories, reference laboratories, and hospital laboratories across North America. Core product portfolios include autoimmune disease diagnostics, infectious disease serology (including viral serology for Zika, COVID-19, Oropouche, and other pathogens), allergy testing, endocrinology assays, bone metabolism markers, neurodegeneration biomarkers, and therapeutic drug monitoring. The company manufactures the IDS i20 random access chemiluminescent analyzer, AP2400 automated T-SPOT.TB testing system (FDA-approved), and distributes the ProciseDx platform. EUROIMMUN US offers training and education through its Academy and Pattern IQ learning platform for ANA pattern recognition. The company provides field service and technical support to laboratory customers. Products are designed for CLIA-certified clinical laboratories and diagnostic reference centers. The company is now part of the Revvity organization.

iScreen Vision, Inc. manufactures the iScreen Vision 3000, a portable photoscreening device designed for pediatric vision screening in clinical settings. The system uses digital imaging technology to detect amblyopia risk factors and serious eye abnormalities in preverbal, preliterate, and developmentally disabled children in seconds. The device screens for refractive errors and conditions including anisometropia, astigmatism, cataract, coloboma, hyperopia, myopia, ptosis, and strabismus. Images are captured and transmitted to iScreen's certified ophthalmic professionals for interpretation, with results typically available in less than five minutes. The technology offers substantially higher accuracy rates (>90%) compared to traditional pediatric vision screening methods (<10%). iScreen Vision serves pediatricians, family practitioners, ophthalmologists, hospitals, health clinics, schools, and community screening programs (Lions Clubs, Kidsight). The company has facilitated screening of over 1.5 million children and serves more than 1,000 pediatricians. The device requires minimal training and operates similarly to a point-and-shoot digital camera. U.S. Federal Law restricts sales to licensed physicians or qualified medical professionals. The company provides on-site and remote training and offers flexible payment options including monthly invoicing and automatic bill pay.

DIESSE Diagnostica Senese S.p.A. is an Italian manufacturer of in vitro diagnostic (IVD) systems headquartered in Siena, specializing in immunochemistry, infectious disease diagnostics, autoimmune testing, and automated erythrocyte sedimentation rate (ESR) measurement. Founded in the 1980s, the company operates as a research-focused Società Benefit with over 180 employees and exports to more than 100 countries. DIESSE manufactures a comprehensive portfolio of automated and manual diagnostic solutions including the CHORUS EVO platform for immunochemistry, VES-MATIC 5 for ESR analysis with AI integration, AUTO-DAT for standardized seroagglutination testing, Enzywell for manual immunochemistry, and iRapid for rapid immunodiagnostics. All products are produced in-house in Italy, emphasizing quality, sustainability, and ethical practices. The company serves clinical laboratories, hematology centers, and infectious disease diagnostics facilities globally.

International Medical Solutions (IMS) is a software and services company specializing in cloud-native medical imaging platforms for diagnostic and educational applications. IMS develops DICOM-compliant viewing solutions built on HTML5 and cloud infrastructure (Google Cloud, Microsoft Azure) that enable healthcare clinicians, radiologists, and researchers to securely view, annotate, and share medical imaging data remotely without local installation or infrastructure overhead. Core offerings include IMS CloudVue (native cloud-based DICOM viewer with real-time performance), IMS CloudSync (cloud storage and synchronization with intelligent caching for offline/online workflows), and IMS Learn (web-based educational platform for creating interactive quizzes and training sessions with full-resolution medical images). The company maintains FDA, Health Canada, and ISO compliance with emphasis on data security, disaster recovery, and business continuity. IMS partners with academic medical centers, health systems, and radiology organizations globally.

TytoCare is an AI-powered remote physical examination platform that enables clinicians to conduct comprehensive diagnostic exams from any location—home or community site. The company's Smart Clinic solutions include FDA-cleared hardware (digital stethoscopes, examination cameras) and advanced diagnostic software that replicates in-person clinical assessments for heart, lungs, throat, ears, skin, abdomen, and vital signs (temperature, heart rate). TytoCare serves 240+ healthcare organizations, 1.6M+ patients, and 40K+ providers globally, with deep integrations across health systems, health plans, and Medicaid programs. The platform features FDA-cleared AI algorithms for detection of pulmonary abnormalities (wheeze, rhonchi, crackles) and clinical decision support. Two primary offerings: Home Smart Clinic for patient self-exams with remote clinician supervision, and Pro Smart Clinic for field-based clinician-conducted exams. Clinical evidence demonstrates 6X higher utilization versus traditional telehealth, 98% remote resolution rate, 8.5% total cost-of-care reduction, and 83 NPS score. Trusted by Corewell Health, Sanford Health, Clalit, Elevance, Presbyterian, and major U.S. health systems.

Oakworks, Inc. is a U.S.-based manufacturer of medical, spa, and wellness equipment founded in 1977 and headquartered in New Freedom, Pennsylvania. Operating from a 91,000 square-foot ISO 13485-certified facility, the company specializes in designing and manufacturing specialized tables and accessories for healthcare, therapeutic, and wellness applications. Product lines include imaging tables, ultrasound tables, exam tables, physical therapy tables, patient positioning devices, spa tables, and massage treatment tables. Oakworks emphasizes ergonomic design, durability, and safety in all offerings, serving professionals in integrative healthcare, physical therapy, athletic training, and wellness centers. The company is committed to domestic U.S. manufacturing and regulatory compliance for medical devices, with over 45 years of experience in design innovation and craftsmanship.

VENOSCOPE manufactures handheld LED transillumination devices designed to assist healthcare providers in visually identifying superficial peripheral veins for IV insertion. The company offers two primary product lines: the VENOSCOPE® II (VT03) for general clinical use and a Neonatal LED Transillumination Device (NT01) specifically engineered for neonatal and pediatric settings. These portable, lightweight devices illuminate subcutaneous tissue to enhance vein visualization, reducing needle insertion attempts and improving patient comfort. The technology employs gentle pressure application and release to highlight changes in vein appearance. VENOSCOPE also supplies disposable protective covers for infection control. The devices are intended for use across diverse clinical environments including hospitals, clinics, and neonatal units. The company emphasizes ease of use and clinical efficacy in reducing patient discomfort during IV placement.

MicroVision, Inc. is a technology company specializing in advanced perception solutions for autonomy and mobility applications using proprietary MEMS-based laser beam scanning and solid-state sensor technologies. Founded in 1993 and headquartered in Redmond, Washington, the company develops and manufactures solid-state LiDAR sensors and perception software for automotive, industrial, security, and defense markets. The company's product portfolio includes the MAVIN long-range LiDAR sensor for small object detection, the MOVIA series (short- to mid-range sensors including MOVIA S and MOVIA L), and the L-CAS 3D LiDAR collision avoidance system for industrial applications. MicroVision also provides the MOSAIK validation software suite for testing vehicle sensors in advanced driver-assistance systems (ADAS) and autonomous driving applications. With 185 employees and technology centers in Redmond, Detroit, and Hamburg, MicroVision delivers robust, reliable LiDAR solutions designed to enable autonomous operations in challenging environments including GNSS-denied areas and 24/7 operations.

F & L Medical Products LLC is a manufacturer and supplier of specialized laboratory, medical, and research supplies headquartered in Vandergrift, Pennsylvania. Operating since 1989, the company specializes in precision sample-handling equipment and radiation protection devices for clinical and research applications. Their product portfolio includes aluminum blocks and racks for PCR and sample storage, electroporation cuvettes for genetic research and molecular biology, temperature-controlled biocoolers for specimen preservation, attenuating gloves for radiation protection, and CT scan shielding systems (AttenuRad) for breast, thyroid, and eye protection in adult and pediatric configurations. The company serves laboratory, diagnostic imaging, and research markets through direct sales and an international distributor network. F & L Medical emphasizes custom manufacturing capabilities, quality testing, and comprehensive product management solutions.

NovaMedUSA, Inc. is a manufacturer and distributor of specialty medical products serving anesthesiology, cardiology, neonatology, and critical care markets. The company specializes in temperature monitoring solutions, including core body temperature probes, neonatal skin temperature sensors compatible with major incubator systems (GE/Ohmeda, Dräger, Atom Medical), and wireless temperature monitoring. Product lines include fiber optic laryngoscopes (PREMIER, standard, LED, and MRI-conditional variants) for intubation procedures, esophageal stethoscopes (LIFESOUND) for heart/breath sound monitoring, and conductive patient warming systems (KOALA for adults and KOALA Infant Warmer for neonates) designed to prevent perioperative hypothermia. NovaMedUSA emphasizes energy-efficient, eco-friendly technology and SCIP-INF-10 compliant products. The company operates customer support Monday–Friday, 8:30 am–8:30 pm EST, with dedicated channels for current customers, prospective buyers, and dealer partners.

Shenzhen Aeon Technology Co., Ltd is a Chinese medical device manufacturer based in Shenzhen. The company designs and produces diagnostic and laboratory equipment targeting healthcare facilities and clinical laboratories. Product portfolio includes the A-series devices (A800L, A200, A201, A310B, A320, A330N, A500 series variants), which appear to span patient monitoring and clinical laboratory analysis applications based on model designations and positioning. The company participates in major medical trade shows including the China Medical Equipment Fair (CMEF) and Hong Kong Electronics Fair, indicating focus on Asian market distribution and emerging market expansion. Manufacturing and after-sales support operations are located in Shenzhen's Bao'an District. Contact channels include dedicated sales and general business inquiry email addresses, with phone support available via China-based telephone numbers. Limited technical specifications or regulatory certifications are visible on the primary website; detailed product datasheets and compliance documentation would require direct vendor engagement. The company operates as a B2B supplier with a focus on equipment rather than consumables or services.

Spectron IR manufactures FDA-cleared medical thermal imaging systems for clinical diagnostic applications. The company supplies high-grade infrared cameras, professional medical imaging software, and turn-key equipment packages designed for thermal imaging clinics and healthcare facilities. Products are optimized for adjunctive diagnostic screening in breast cancer detection, peripheral vascular disease, neuromusculoskeletal disorders, inflammatory conditions, and thyroid abnormalities. Systems feature microbolometer detector technology, adaptive focus capabilities, and dedicated clinical software with integrated alarms. Spectron IR offers multiple deployment options from entry-level systems for startup clinics to professional workstations with remote-controlled camera positioning and ergonomic design. All packages include professional-grade software, dedicated computer hardware, and complimentary equipment training and technical support.

PixCell Medical manufactures HemoScreen, a portable point-of-care (POC) complete blood count (CBC) analyzer designed to perform complex hematological testing in non-laboratory settings. The device delivers results in approximately 5 minutes and includes a 5-part differential count with clinical accuracy comparable to centralized laboratory instruments. The technology employs microfluidics, Lab-On-A-Cartridge design, and viscoelastic focusing—a proprietary physical phenomenon that aligns blood cells into a monolayer for optical analysis. HemoScreen accepts both venous and capillary (finger-stick) samples, enabling deployment in emergency departments, urgent care clinics, oncology practices, mental health facilities, primary care centers, and homecare settings. The company markets to healthcare practitioners and institutions seeking rapid turnaround for critical hematological decision-making. Testimonials from NHS trusts, university medical centers, and international healthcare systems indicate clinical adoption in the UK, Sweden, Denmark, and US. The device has received FDA clearance and is recognized by clinical organizations including AACC for disruptive technology. Manufacturing and service capabilities support both institutional and point-of-care deployment models.

Tecan Group AG is a global life sciences and diagnostics company specializing in laboratory automation, microplate readers, microplate washers, liquid handling systems, and molecular diagnostics solutions. The company serves research institutions, clinical laboratories, and diagnostic centers with a comprehensive portfolio of hardware platforms, reagents, software, and custom automation solutions. Key product lines include the Fluent® and Veya® laboratory automation workstations, Freedom EVO® platform, microplate readers (Spark®, Infinite® series, Sunrise™), and microplate washers (HydroFlex™, HydroSpeed™). The diagnostics division provides mass spectrometry sample preparation systems, positive pressure workstations (Resolvex), and pre/post-analytical automation solutions. Tecan also manufactures next-generation sequencing (NGS) library prep reagents and consumables under brands including Celero, Revelo, and Ultralow DNA-Seq kits. The company's software offerings (FluentControl™, Freedom EVOware®, Magellan™, i-control™, Introspect™) support workflow automation and data management across genomics, proteomics, immunoassay, and clinical diagnostics applications. Manufacturing and OEM partnering services through the Partnering division include liquid handling components, robotic technologies (Cavro systems), and contract manufacturing capabilities. Tecan maintains ISO 13485 quality certification and operates globally with headquarters in Switzerland and significant operations in the US, Europe, and Asia-Pacific. Products are marketed to pharmaceutical research, biotech, clinical laboratories, and diagnostic service providers.

Lumitex, Inc. is a 40-year-old medical lighting design and manufacturing company headquartered in Brecksville, Ohio. The company specializes in designing, developing, and delivering custom lighting systems for medical device manufacturers, CDMOs, and OEMs across multiple therapeutic and diagnostic applications. Core product lines include surgical retractor lighting systems, light therapy solutions (including phototherapy for neonatal jaundice), and medical Human-Machine Interface (HMI) lighting for displays and ambient illumination in imaging environments such as MRI systems. Lumitex offers end-to-end capabilities spanning concept through full-scale production, including rapid prototyping, agile development, and supply chain management. The company operates globally with manufacturing facilities in Taiwan (Asia operations, focused on backlighting and HMI products) and Celaya, Mexico (component production and final assembly). Lumitex operates under U.S. FDA Good Manufacturing Practices, holds ISO 13485 (medical devices) and ISO 9001 (quality management) certifications, and maintains a global Quality Management System. The company provides flexible development approaches tailored to client needs, from simple solutions delivered in weeks to complex multi-month system builds. Beyond product design and engineering, Lumitex offers testing, compliance, and regulatory support. The company has been recognized as a 2022 Smart Business Evolution of Manufacturing Award honoree for innovative Northeast Ohio manufacturing.

Eforto develops and markets the Eforto® System, a validated digital solution for monitoring muscle health and vitality capacity through grip strength testing and muscle fatigability assessment. The platform comprises three integrated components: the Eforto® Vigorimeter (a medical-grade ergonomic handgrip dynamometer with auto-calibration pressure sensor, weighing only 100g for use across all patient populations), the Eforto® App (providing guided self-testing with validated protocols delivering results in under 5 minutes), and Eforto® Metrics (a cloud-based remote monitoring dashboard with FHIR API integration for tracking biomarkers over time and generating actionable insights via traffic-light color-coded reporting). The system measures grip strength, muscle fatigability, and self-perceived fatigue as biomarkers for vitality capacity per WHO definition. Clinical evidence is published in The Lancet Healthy Longevity and Springer journals, establishing validity and reliability in older persons. The solution serves three market segments: health & fitness (consumer wellness and health span expansion), medical & healthcare (clinical decision-making, rehabilitation, and disease management), and clinical research (customizable research protocols). Trusted by academic medical centers including Kansas University Medical Center, Erasmus MC, and Radboud UMC. Compliant with HIPAA, GDPR, and ISO 27001; supports interoperable data processing and secure cloud infrastructure. Suitable for hospital rehabilitation departments, primary care, geriatric clinics, and home-based monitoring programs.

MDF Instruments is a medical device manufacturer established in 1971, headquartered in Rincón, Puerto Rico. The company specializes in the design, manufacturing, and distribution of high-quality stethoscopes and medical diagnostic instruments for healthcare professionals. Primary product lines include the ProCardial® Titanium Cardiology stethoscope line, MD One® adult stethoscopes, MD One® Epoch® titanium stethoscopes, and the Mprint collection—a curated line of printed and patterned stethoscopes featuring custom designs, animal prints, art-inspired patterns, and glitter finishes. MDF also distributes branded medical apparel and scrubs from manufacturers including Cherokee, Healing Hands, and OliveUs. The company markets products to physicians, nurses, medical students, and healthcare facilities across the United States. Stethoscopes feature titanium and stainless-steel construction with dual-head auscultation design. MDF emphasizes product quality, aesthetic customization, and professional-grade acoustic performance. The company operates an e-commerce platform and maintains a corporate social responsibility program called Crafting Wellness, which includes medical equipment donation initiatives. No specific FDA 510(k) clearances, ISO certifications, or regulatory documentation are visible on the fetched homepage content.

SEKISUI Diagnostics is a global leader in diagnostic reagents, biochemistry products, and point-of-care testing solutions with over 40 years of industry experience. The company manufactures and supplies clinical chemistry reagents, performing over 1.8 billion tests annually worldwide. Core product lines include Clinical Chemistry reagents for laboratory analyzers, Point-of-Care Testing (POCT) solutions in multiple formats to enable rapid diagnosis in office and clinic settings, and specialty biochemical enzymes for diagnostic reagent and biosensor manufacturers. SEKISUI also provides Blood Collection Tube Raw Materials and pre-analytic systems for plasma collection tubes, serving blood collection manufacturers globally. The Metrix® COVID/Flu Test represents their molecular diagnostics portfolio, offering point-of-care detection and differentiation of SARS-CoV-2, Flu A, and Flu B with small footprint and streamlined workflow. Beyond products, SEKISUI offers Biopharma Services supporting biotherapeutic and pharmaceutical manufacturing, technical transfer, and process scale-up. The company serves core laboratories, healthcare providers, in vitro diagnostics manufacturers, and distributors. SEKISUI combines analytical accuracy with operational efficiency, positioning products for cost containment and outcome improvement across clinical settings. The organization emphasizes patient-centric diagnostic solutions and maintains comprehensive technical and educational support for laboratory and clinical professionals.

Bioplate, Inc. is a California-based manufacturer specializing in cranial and neurosurgical implants and instrumentation for over 25 years. The company produces a narrowly focused portfolio of titanium plates and screws, bioresorbable implants, and PEEK custom plates designed for neurosurgical and maxillofacial applications. Product offerings include sterile surgical kits for neurosurgery, maxillofacial surgery solutions, the PRO-DEX surgical driver, and the Aura wireless ICP (intracranial pressure) monitor for neuromonitoring. All products are manufactured from proven biomaterials and designed to address the specific challenges of cranial reconstruction and neurosurgical procedures. The company positions itself as a value-conscious supplier, emphasizing rapid domestic fulfillment from California, competitive pricing, inventory management support, and personalized customer service. While specific regulatory certifications are not detailed on the public-facing site, the nature of the products (implants, surgical instruments, monitoring devices) indicates FDA 510(k) clearance and adherence to medical device standards. Bioplate serves neurosurgeons, hospitals, and surgical centers seeking cost-effective, reliable solutions for cranial fixation and neuromonitoring.

Fudakang Industrial Co Ltd is a medical device manufacturer specializing in homecare monitoring equipment and personal health devices. The company produces a range of blood pressure monitors, thermometers (infrared and digital), and related consumables designed for home use and daily patient monitoring. Their product portfolio includes multiple models of automated blood pressure monitors with varying cuff sizes (standard through XXL), digital thermometers with multiple display options, accessories such as probe covers and replacement cuffs, and AC-DC power adapters. Products feature multilingual interfaces supporting English and Spanish, addressing diverse patient populations. The company serves seniors and individuals requiring ongoing in-home health monitoring. Fudakang markets its devices through a direct B2B and B2C distribution model, offering product catalogs and dealer/partnership programs. The company appears to maintain regulatory compliance with UL certifications on power adapters. Product lines are identified by model codes (e.g., FT-B22Y, FT-C02-V, BT-A21CN, 3R-480140-01), suggesting established manufacturing and quality control processes. The website indicates warranty registration capabilities and customer support infrastructure. While specific FDA 510(k) or ISO 13485 certifications are not explicitly mentioned on the homepage, the product quality and design suggest compliance with medical device regulations for home monitoring equipment.

UpRight Science develops FDA-cleared balance assessment and fall-risk detection technology for clinical and research use. The company's core offering is a medical-grade, AI-driven platform that quantifies balance and gait dynamics to identify fall risks, neurological decline, and medication side effects. Their technology integrates machine learning algorithms trained on biomechanical datasets to provide clinicians and researchers with actionable insights for patient stratification and early intervention. The platform is validated in clinical trials and marketed as addressing balance as "the sixth vital sign"—positioning fall prevention as a critical health metric alongside traditional vital signs. UpRight Science targets healthcare providers, physical therapy clinics, geriatric care facilities, and research institutions. The technology combines motion analysis with predictive analytics to detect deviations linked to neurodegenerative diseases and other conditions affecting balance and gait. The company emphasizes evidence-based development leveraging decades of balance science research. Their go-to-market approach includes direct sales to clinical and research institutions via demonstrations and proof-of-concept studies.

Imalogix is a cloud-based healthcare technology platform specializing in AI-driven medical imaging analytics and compliance solutions for radiology departments. The company's end-to-end image management system transforms imaging data into actionable insights using proprietary deep learning algorithms and machine learning tools. Core capabilities include real-time radiation dose tracking and optimization, automated image quality assessment, technologist performance evaluation, protocol normalization, and one-click CMS compliance reporting. The vendor-agnostic platform integrates seamlessly with existing imaging systems and PACS infrastructure, enabling hospitals and healthcare providers to enhance workflow efficiency, reduce regulatory burden, and improve patient safety. Imalogix addresses critical compliance requirements including eCQM standards and radiation dose management mandates while eliminating manual protocol mapping and streamlining quality assurance processes.

Sage Services Group is an FDA-registered repair and refurbishment facility specializing in patient monitoring device repairs, replacement parts, cables, and accessories. Founded in 2006, the company serves healthcare technology managers and biomedical engineering departments across the US, offering cost-effective alternatives to original equipment manufacturer (OEM) services. The company repairs patient monitoring equipment including telemetry transmitters and related devices at its Charleston, South Carolina facility and sells FDA-approved accessories compatible with major manufacturers' equipment. Core service offerings include equipment repair with a typical 5–7 day turnaround, refurbished equipment sales, replacement parts, reusable and disposable cables and accessories, and protective Guardian Cases. Sage advertises 25–40% cost savings compared to OEM pricing while maintaining compatibility and quality standards. The company maintains ISO 9001 and ISO 13485 certifications, reflecting its commitment to quality management and medical device manufacturing standards. Customers include hospital biomedical engineering departments and healthcare facilities seeking to extend device life and reduce capital expenditure on new equipment. The company operates an online repair request system and maintains an inventory of common cables and accessories to minimize stockouts and delivery delays typical of OEM channels.

Radnostix, Inc. (formerly International Isotopes Inc., established 1995) is a domestic supplier of radioisotope products, medical devices, and nuclear medicine infrastructure solutions. The company operates across five primary business segments: Calibration & Reference Products (radioactive standards and quality control solutions for nuclear medicine and industrial calibration); Theranostics Products (I-131, Tb-161, and theranostic precursors for targeted radionuclide therapy); Co-60 & High Energy Products (high-activity cobalt-60 and other industrial and medical sources); Medical Devices & Equipment (shielding solutions, instruments, and lab equipment for nuclear medicine facilities); and Bulk Isotope Sales for manufacturers, research institutions, and radiopharmaceutical production. The company recently achieved second-highest annual revenue in its history (FY2025), with 21% growth in calibration and reference products driven by PET-focused innovation. Radnostix operates under regulated frameworks including NRC licensing and maintains exclusive North American distribution agreements for advanced radiation monitoring and measurement instrumentation. The company is actively engaged in facility upgrades, medical device pipeline advancement, and infrastructure investments to support long-term growth in the radioisotope and theranostics market.

AION Biosystems develops and commercializes the AION TempShield™, an FDA-cleared Class II medical device for continuous, non-invasive body temperature monitoring. The TempShield is a wearable sensor designed for 24/7 real-time tracking with up to 90 days of battery life per charge. The device features Bluetooth connectivity, mobile app integration, and seamless electronic medical record (EMR) integration, supported by a dedicated clinician dashboard. Reimbursable under CMS code 99454, the TempShield targets early detection of infection-related complications across multiple clinical settings: oncology (60% of cancer deaths are infection-related), post-operative care (23.7% of surgical patients experience postoperative fever), pediatrics (75,000 children develop sepsis annually in the U.S.), long-term care facilities, and general sepsis management. The device addresses a critical care gap by enabling earlier identification of infection before progression to severe sepsis or organ failure, potentially reducing hospitalizations, readmissions, and associated healthcare costs. Clinical evidence cited on the company website demonstrates that each hour of delay in antibiotic administration for sepsis increases mortality risk by 7.6%, making early detection instrumental to patient outcomes. Manufacturing and regulatory capabilities include FDA 510(k) clearance and integration with major health information systems.

MESM LLC is now part of Resonant Clinical Solutions, a company specializing in equipment solutions and logistics support for clinical trials. The company provides end-to-end services encompassing sourcing, delivery, calibration, and equipment removal. MESM's core competency is infusion pump configuration and management, with technical expertise in ensuring seamless pump operation and patient safety throughout clinical studies. Beyond infusion systems, MESM supplies a broad range of clinical trial equipment including monitoring systems, refrigeration units, and diagnostic devices. The company delivers comprehensive clinical trial logistics support, including equipment procurement, management of ancillary supplies, and global distribution capabilities. MESM serves clinical research organizations (CROs), pharmaceutical sponsors, and contract research organizations (CROs) requiring reliable, calibrated medical equipment for multi-site and international trials. The organization emphasizes technical support, regulatory compliance, and preventing disruptions to trial operations. While specific regulatory certifications are not detailed in the available content, the nature of their work with clinical trials implies adherence to FDA and ICH-GCP standards.

Capnia, Inc. manufactures the CoSense® ETCOc (end-tidal carbon monoxide) Monitor, a non-invasive diagnostic device for neonatal jaundice management. The device measures hemolysis rate in newborns through breath testing, providing rapid detection of elevated bilirubin production within five minutes. CoSense® is FDA-cleared and endorsed by the American Academy of Pediatrics (AAP) as the gold-standard diagnostic test for identifying hemolytic conditions in newborns prior to discharge. The technology directly measures end-tidal carbon monoxide levels, which correlate with active hemolysis and unconjugated bilirubin overproduction, helping clinicians distinguish high-risk hemolytic cases from benign neonatal jaundice. Clinical evidence demonstrates that ETCOc testing reduces readmissions for hyperbilirubinemia, decreases unnecessary blood tests by approximately 50%, reduces phototherapy utilization by 20%, and lowers overall healthcare costs. The device supports universal screening protocols and is designed for integration into obstetric and neonatal intensive care workflows. Capnia's approach addresses kernicterus prevention by enabling early identification and treatment of hemolytic disease, particularly relevant given the narrow window for bilirubin management before discharge at 48–72 hours of life, when peak serum bilirubin typically occurs 3–5 days post-birth.

Examinetics is a nationwide occupational health services provider specializing in regulatory compliance, safety consulting, and workplace injury management. The company delivers comprehensive employee health testing and medical surveillance programs including audiometric (hearing) testing, respirator fit testing and medical clearance, spirometry, drug and alcohol testing, pre-employment and post-offer medical exams, ergonomic assessments, and return-to-duty/fitness-for-duty evaluations. Examinetics serves the full worker lifecycle from pre-employment screening through exit medical compliance and record retention. The company operates 140+ mobile health screening units and partners with a network of over 6,500 occupational health clinics nationwide, offering on-site testing at client facilities, near-site clinic access, and on-demand digital testing platforms. Services include medical surveillance for OSHA and MSHA regulatory compliance (hearing conservation, silica exposure, noise surveys, air sampling), safety consulting and audits, industrial hygiene written programs, workplace injury triage and case management, and centralized data management with secure online portal access for test results and compliance documentation. The company emphasizes rapid turnaround (same-day reporting), professional technician credentials including occupational audiologists, and integration of multiple service delivery methods to minimize operational disruption. Examinetics caters to manufacturing, construction, mining, chemical processing, utilities, and other industries with respiratory hazard or noise exposure requirements.

Neuroptek is a Canadian-based medical device company specializing in portable, smartphone-integrated eye-tracking and vision testing technology. The company's primary offering is EyeMirage™, a dual-lens optical device paired with a mobile application that enables comprehensive vision assessment and eye movement analysis using standard smartphones. The EyeMirage™ system performs objective measurements including visual acuity, automated visual field testing, color vision assessment, saccadic eye movement analysis, and convergence testing—clinically relevant for concussion diagnosis and neuro-ophthalmologic evaluation. The device accommodates two smartphones simultaneously (one per eye) with custom cases and synchronized dual-screen presentation capability, allowing precise eye-tracking via front-facing camera capture. The companion mobile app (iOS and Android) integrates test administration, personalized health record storage, appointment scheduling, and result documentation. Key clinical applications include sports medicine concussion evaluation, traumatic brain injury assessment, and general neuro-ophthalmologic diagnostics in field, clinic, and home settings. The platform targets team physicians, sports medicine professionals, eye care providers, and institutional settings seeking portable, objective eye-tracking diagnostics. Leadership includes Dr. Behzad Mansouri (CEO, neuro-ophthalmologist and neuroscientist) and Dr. Neda Anssari (CFO, neurologist and concussion specialist), both co-inventors. The company has published extensively in peer-reviewed literature on eye-tracking biomarkers for traumatic brain injury. Note: EyeMirage™ is in investigational status and not yet licensed for commercial sale; pre-order options are announced as forthcoming.

LCR Hallcrest, LLC (trading as Thermographics) is a US-based manufacturer of thermochromic and photochromic specialty inks, dyes, paints, and consumer products that change color in response to temperature and UV light exposure. The company operates an FDA-registered, ISO 13485-certified facility in Glenview, Illinois, manufacturing made-in-USA products. Primary product lines include Feverscan® forehead thermometers for fever detection in clinical and consumer settings, thermochromic and photochromic specialty inks for industrial and educational applications, and consumer items such as aquarium thermometers, battery testers, and propane tank gauges. Thermochromic liquid crystals are used in flow visualization and heat transfer research. The company offers thermochromic test kits, educational materials, and custom color-change promotional products. Products leverage liquid crystal technology and environmental-responsive inks for temperature monitoring, safety applications (vehicle heat alerts, hot water gauges, baby bath thermometers, choking hazard testers), and energy conservation programs. The company serves healthcare facilities, research institutions, educational markets, and consumer segments globally. Manufacturing capabilities include screen printing, ink formulation, and product assembly. All products comply with relevant safety and regulatory standards for medical and consumer use.

Solvemed Inc. develops PuRe™ Pupillometer, a smartphone-based FDA Class I medical device for objective pupillary assessment in critical care settings. The device employs computational pupillometry to measure pupil size and reactivity with superior accuracy across varying ambient light conditions—addressing a key limitation of conventional infrared pupillometers, which show significant measurement variability in different lighting environments. The PuRe™ score is a lighting-invariant metric derived from exposure-corrected pupillary parameters and is openly published for research benefit. The software integrates securely with major hospital EMR systems (Epic, Oracle, Athena, Meditech, Allscripts, eClinicalWorks) via HIPAA-compliant cloud infrastructure with SOC2 certification. The solution eliminates disposable costs and hardware logistics while providing immediate EMR data upload. Clinical collaborations span Emory Healthcare, NHS Oxford, Harvard-affiliated institutions, and UK research centers. Designed for neuro-ICU, medical-ICU, cardiac-ICU, surgical-ICU, trauma centers, stroke units, and emergency departments. No hardware required; operates on iOS devices with Face ID authentication. The device enables standardized, reproducible neurological assessment comparable to automated vital-sign measurement.

Radiometer Medical APS is a global acute care diagnostics company with over 70 years of industry experience. The company manufactures and integrates blood gas analyzers, point-of-care testing syringes, point-of-care IT solutions, and associated laboratory services. Operating across 59 countries with 3,780+ employees, Radiometer's portfolio addresses critical diagnostic workflows in hospitals and acute care settings. The company reports testing approximately 300,000 samples daily with its products, impacting approximately 4 million patients annually. Radiometer's core offerings include automated blood gas testing systems, integrated IT platforms for regulatory compliance and data management, and consumable supplies for acute care diagnostics. The company serves hospital networks, emergency departments, and intensive care units seeking standardized, automated diagnostic workflows. Radiometer operates as part of Danaher Corporation and maintains a customer portal using Microsoft Azure AD authentication, indicating enterprise-level software and data security infrastructure. The company's mission emphasizes streamlining diagnostic workflows to enable clinicians to focus on patient care in critical settings.

Medinova is a medical device manufacturer specializing in premium stethoscopes and diagnostic auscultation instruments. The company designs and produces acoustically engineered stethoscopes for healthcare professionals across multiple specialties, including cardiology, pulmonology, and pediatrics. All Medinova stethoscopes feature aircraft-grade stainless steel construction, latex-free tubing, and advanced acoustic chambers engineered to isolate ambient noise and enhance body sound clarity across high and low frequencies. The product line emphasizes ergonomic design for extended clinical use, with lightweight tubing and soft ear seals to reduce practitioner fatigue during long shifts. Medinova serves a global market, with products distributed across 50+ countries and trusted by medical students, clinicians, and specialists. The company maintains an in-house R&D capability focused on continuous acoustic innovation and clinical validation. Each model undergoes acoustic testing and clinical validation before market release. Manufacturing utilizes precision engineering techniques to ensure consistent sound quality and durability. The company operates a B2C and B2B distribution model through its website and professional healthcare channels.

Bluedrop RPM is a remote patient monitoring (RPM) company specializing in diabetic foot ulcer (DFU) prevention and early detection. The company develops at-home foot scanning and monitoring solutions designed for patients with diabetes who are at high risk for peripheral neuropathy-related foot complications. Bluedrop's primary offering is OneStep, a smart-scale foot scanner that captures high-resolution images and thermal data in under 30 seconds per day. The device pairs with EveryStep, a cloud-based monitoring service that analyzes scan data, identifies risk indicators, and communicates findings directly to patients and their healthcare providers when clinical escalation is warranted. The platform emphasizes ease of use and consistent patient engagement to enable early-stage DFU detection, which significantly reduces treatment costs and clinical severity. Bluedrop reports an average patient compliance of approximately 4 scans per week, with detected ulcers graded at Stage 1 upon clinical escalation. The company serves both individual patients seeking convenient at-home foot health management and healthcare providers seeking to reduce preventable complications in their highest-risk diabetic populations. Bluedrop operates with offices in Houston, TX and Galway, Ireland, positioning the company for both North American and European markets.

Werfen (formerly Immucor, Inc.) is a global leader in specialized diagnostics for transfusion and transplantation medicine. The company manufactures a comprehensive portfolio of serology-based reagents, automated instruments, and molecular diagnostic products serving blood banks, transfusion services, clinical laboratories, reference laboratories, donor centers, and transplant programs worldwide. Core product lines include: (1) Transfusion diagnostics—blood typing, antibody screening and identification, platelet serology, and HLA donor screening assays; (2) Transplant diagnostics—HLA typing kits (including NanoTYPE® HLA-11 Plus), HLA and non-HLA antibody detection products, and post-transplant monitoring assays; and (3) Coagulation diagnostics for heparin-induced thrombocytopenia (HIT) and thrombotic thrombocytopenic purpura (TTP) detection. Signature automated platforms include the NEO® and NEO Iris® systems for immunohematology automation, and Echo Lumena® for antibody identification with enhanced imaging. The company acquired Omixon (Hungary) to expand HLA typing capabilities. Werfen operates globally across hospital blood banks, reference laboratories, and transplant centers, leveraging customer-centric support with field representatives who possess transfusion and transplant technical expertise. The company emphasizes regulatory compliance, quality assurance, and comprehensive technical and educational support to streamline laboratory workflows and improve patient outcomes in transfusion and transplant medicine.

Bedfont Scientific Ltd is a UK-based medical technology company founded in 1976 and headquartered in Harrietsham, Kent. As a second-generation family-owned business with over 48 years of experience, Bedfont specializes in designing, manufacturing, and distributing non-invasive breath and gas monitoring instruments for medical diagnostics. Operating in more than 76 countries through a network of over 100 distributors, the company is a recognized world leader in breath analysis technology. Bedfont's product portfolio includes the Smokerlyzer® series for smoking cessation via CO breath analysis, the NObreath® FeNO monitor for asthma diagnosis and airway inflammation management, the Gastrolyzer® range for detection of gastrointestinal disorders and food intolerances using hydrogen and methane breath testing, the Medi-Gas Check range for medical gas pipeline verification and quality assurance, the Breathacise® incentive spirometer for respiratory capacity training, and the CELLER8® device for clinical applications. The company emphasizes innovation in non-invasive diagnostics and has received multiple awards including Business of the Year 2024.

Bio-Nuclear of PR, Inc is a premier supplier of medical and laboratory equipment serving healthcare providers, laboratories, and patient care facilities across Puerto Rico and the Caribbean for over three decades. The company distributes a comprehensive range of clinical diagnostic equipment, healthcare solutions including bone densitometry and ultrasound systems, anatomical pathology instruments, and reference laboratory solutions designed for high-volume sample processing. Bio-Nuclear partners with major manufacturers including GE HealthCare and Sysmex, providing access to cutting-edge diagnostic technologies. The company's product portfolio encompasses clinical diagnostic systems with precision and reliability for clinical diagnosis, patient care solutions customized for superior patient experience, vanguard pathology technologies for precise diagnosis, and workflow solutions tailored for large-volume laboratory operations. Bio-Nuclear serves hospitals, diagnostic centers, reference laboratories, and industrial applications across the Caribbean region. The company maintains a customer service infrastructure and supports various healthcare professionals including laboratory directors, managers, biomedical technicians, medical technologists, pathologists, sonographers, and purchasing agents.

AccuVein is a medical device manufacturer specializing in near-infrared (NIR) vein visualization technology for vascular access procedures. The company develops handheld vein finder devices that enable healthcare professionals to visualize peripheral veins, valves, and bifurcations not visible to the naked eye, improving peripheral IV catheter placement success rates and reducing procedure time and complications. AccuVein's primary products serve acute care settings (emergency departments, ICUs, general wards), non-acute care environments (outpatient clinics, home care), and aesthetic/cosmetic medicine practices. Clinical evidence supports the technology with 92% first-attempt success rates for IV placement, 78% reduction in procedure time, 45% decrease in escalation calls, and 39% reduction in patient pain. The company manufactures multiple generations of vein visualization devices, including the AV500, AV600 (fourth-generation model recently launched), and associated accessories such as the HF580 Powered Stand for hands-free mobile applications. AccuVein's devices are recommended by leading professional societies for pre-insertion vascular assessment and are positioned to improve clinical outcomes, operational efficiency, staff well-being, and healthcare equity by enabling successful venous access across diverse patient populations.

PartsSource, Inc. is a B2B medical equipment parts and service distributor serving hospitals, clinics, and healthcare facilities across the United States. The company operates a comprehensive online marketplace specializing in replacement parts, consumables, repair services, and accessories for a broad range of diagnostic imaging, patient monitoring, respiratory, surgical, and facility maintenance equipment. PartsSource maintains inventory of OEM parts from leading manufacturers including GE Healthcare, Philips, Stryker, Mindray, Welch Allyn, CareFusion, and others. Product categories include ultrasound probes and transducers, ventilator components, batteries and power supplies, infusion pump accessories, fetal monitoring transducers, surgical table components, sterilization equipment filters, maintenance kits, and specialty cables and connectors. The company provides repair services for equipment such as GE Healthcare fetal transducers and probe disinfectors. PartsSource operates a searchable parts database organized by manufacturer, model, and device category (ultrasound, patient monitoring, respiratory, beds/furniture, radiographic imaging, MRI, X-ray, C-arms, catheterization lab, and facility maintenance). The platform supports procurement workflows with order tracking, shopping history, and direct contact for quotes. The company's tagline is "Ensuring Healthcare is Always On®," emphasizing focus on equipment uptime and operational continuity. No specific regulatory certifications (FDA, ISO) are explicitly stated on the home page, though the site indicates active partnerships with major OEM suppliers.

SCHILLER Americas is a cardiopulmonary diagnostic device manufacturer and solutions provider with 50 years of innovation in medical diagnostics. The company specializes in electrocardiography (EKG), lung function testing, patient monitoring systems, and diagnostic station equipment. Their product portfolio includes EKG devices, the DS-20 Diagnostic Station, lung function testing systems (including the TREMOFLO), and multiparameter patient monitoring solutions. SCHILLER serves multiple market segments: general practice clinics, hospitals, specialized lung function laboratories, and government distributors. The company emphasizes integration of device hardware, clinical software, and ergonomic user interface design under their "Art of Diagnostics" philosophy. They offer service solutions, equipment trials (SCHILLER Trial Program), and ADA-compliant device options to support accessible patient care. Based in Doral, Florida, SCHILLER Americas operates as the North American division of the SCHILLER Group, a globally recognized medical device manufacturer. Their solutions are deployed across primary care, acute care, pulmonary specialty, and occupational health settings.

Ondal Medical Systems GmbH is a global manufacturer of suspension arm systems and medical pendant carrier systems for hospitals, operating rooms, intensive care units, and diagnostic imaging areas. Founded in 1945 and headquartered in Hünfeld, Germany, the company operates as a B2B supplier specializing in customized ODM/OEM solutions for hospital suppliers and medical technology companies. With over 3 million suspension arms installed in approximately 70% of hospitals worldwide, Ondal designs and manufactures medical device suspension systems, surgical light positioning systems, medical display mounting solutions, and ceiling-mounted supply units. The company holds CE and UL certifications and complies with ISO 13485 medical device standards. Ondal provides comprehensive services including installation, maintenance, repairs, technical support, and product training through a dedicated Technical Service Department. Their solutions optimize workflow efficiency and ergonomics across operating rooms, radiology departments, examination rooms, and ICU environments.

BLOXR Solutions is a USA-based manufacturer of proprietary scatter radiation protection products, including non-lead X-ray aprons, vests, skirts, thyroid collars, and specialized protective garments. The company's patented XPF technology combines barium sulfate and bismuth oxide to deliver 0.5 mm lead equivalent attenuation without lead, tungsten, or toxic heavy metals. Product portfolio includes frontal aprons, 2-piece vest-and-skirt sets, thyroid collars and caps, breast protection inserts, pregnancy shields, shin guards, arm sleeves, eyewear, mobile shields, and ULTRABLOX attenuating hand cream. BLOXR serves hospitals, surgical centers, cardiac catheterization labs, interventional radiology departments, orthopedic facilities, imaging centers, veterinary practices, and dental offices. All garments feature customization options including monogramming, logo embroidery, and dosimeter pockets. Manufacturing is USA-based. Products are independently validated for radiation attenuation and designed to reduce occupational exposure for clinicians and patients during fluoroscopic, interventional, and radiographic procedures.

i-SENS is a global biotechnology company headquartered in South Korea and operating in over 110 countries, including the United States and Europe. The company is the market leader in Korea's blood glucose monitoring device market and specializes in blood glucose management systems, continuous glucose monitoring (CGM) systems, in vitro diagnostics (IVD), and veterinary diagnostic solutions. i-SENS manufactures the CareSens line of self-monitoring blood glucose systems, which meets ISO 15197:2013 accuracy standards for hematocrit and interference criteria. The CareSens Air continuous glucose monitoring system is the first domestically produced CGM in Korea with CE certification, providing real-time glucose data and trend analysis for diabetes management. The company's IVD System leverages whole blood-based diagnostic technology for point-of-care testing applications. i-SENS operates with an annual production capacity of 2.1 billion blood glucose test strips, supporting millions of patients globally. The company maintains regulatory compliance with FDA and CE certification standards. Recent partnerships include a transformational collaboration with LifeScan to launch the OneTouch® Continuous Glucose Monitoring System, leveraging i-SENS technology. The company serves healthcare systems, diabetes management clinics, point-of-care diagnostic facilities, and veterinary care providers. i-SENS is committed to advancing diabetes care innovation and expanding access to glucose monitoring solutions worldwide.

Integrated Medcraft LLC is a B2B medical distributor and supplier specializing in emergency medical equipment, trauma care supplies, and field medical solutions. The company serves Veterans Affairs, law enforcement, EMS, and military/tactical communities, with a DLA ECAT contract (SPE2DV-24-D-0017) indicating federal government qualification. Product lines include: hemorrhage control and trauma supplies (TrueClot brand hemostatic products), thoracic trauma management (chest seals), patient warming and transportation equipment, splinting and immobilization devices, airway management tools, transfusion and medication delivery systems, monitoring and diagnostic equipment, surgical and wound closure supplies, and training supplies with anatomical manikins. The company distributes multiple branded product lines including FORWARD (IFAKs and field procedure kits), APLS, TrueClot, and represents partners including Halo Seal, RevMedX, Nonin, SAM Medical, Teleflex, Compression Works, and others. Integrated Medcraft operates as a reseller and distributor rather than a manufacturer, curating emergency medical equipment for tactical, pre-hospital, and institutional use. The company emphasizes domestically-made products (TrueClot is USA-manufactured) and offers customizable trauma kits. Marketing targets military personnel, first responders, and government procurement with imagery emphasizing veterans and community service. The company provides downloadable product catalogs, buyers guides with NSN (National Stock Numbers), and federal contract documentation.

ACON Laboratories, Inc. is a US FDA-registered global medical device manufacturer specializing in point-of-care testing (POCT) and immunoassay products. Headquartered in San Diego, California, the company develops and manufactures diagnostic solutions across four primary product lines: Point of Care, Immunoassays, Molecular Diagnostics, and Animal Health. Products serve hospitals, clinical laboratories, physician offices, blood banks, pharmacies, and veterinary clinics worldwide. The On Call® Blood Glucose Meter Family is designed for glucose monitoring and diabetes management. Mission® brand includes urine reagent test strips, urine analyzers, and handheld devices for cholesterol, coagulation, and hemoglobin measurement. HealthyMe® provides urinary tract infection (UTI) detection reagent strips. Flow flex® is the newest lateral flow rapid testing brand, offering multiplexed home tests including the recently FDA 510(k)-cleared Flow flex® Plus RSV + Flu A/B + COVID multiplex rapid antigen test for ages 6 months and up. The company's ACON brand offers lateral flow rapid tests for pregnancy, cancer markers, and infectious disease screening, including SARS-CoV-2 antibody and antigen tests. Distinct® provides pregnancy rapid tests using qualitative chromatographic immunoassays. Foresight® offers allergen immunoblot testing for 30 allergens on a single strip. Promotor® provides nucleic acid extraction systems and PCR quantitative test kits for HBV, HCV, HPV 16/18, HPV genotyping, tuberculosis, and HLA-B27. CentriVet® serves veterinary diagnostics with dual ketone/glucose meters and urine reagent strips. ACON maintains US FDA registration, provides contract manufacturing and OEM services, and holds multiple FDA 510(k) clearances for its diagnostic products.

Ametris (formerly ActiGraph) is a digital health technology (DHT) company specializing in wearable medical devices and remote monitoring platforms for clinical research and drug development. The company provides FDA-cleared, medical-grade wearable devices paired with a scalable remote monitoring platform to capture objective, real-world patient data across multiple clinical domains. Ametris delivers an integrated, end-to-end solution combining hardware, cloud-based software, proprietary algorithms, and comprehensive operational and scientific support services. Core measurement capabilities include physical activity, gait and mobility analysis, sleep behavior monitoring, vital signs tracking, and cardinal symptom assessment. The platform is purpose-built to support all phases of the clinical trial lifecycle—from study design and site training to data collection, processing, archiving, and real-time monitoring. Ametris has established expertise in neuromuscular disorders, oncology, neuroscience, sleep medicine, and metabolic diseases. The company serves pharmaceutical sponsors, biotechnology firms, clinical research organizations (CROs), academic institutions, and hospital research networks across 150+ countries. With over 20 years of remote data capture expertise, 30,000+ peer-reviewed scientific publications supporting its technologies, and operational involvement in 285+ industry-sponsored clinical trials, Ametris positions itself as a scientific partner rather than a technology vendor alone. Services include endpoint design consultation, algorithm validation, regulatory strategy support, and DHT data interpretation. The company maintains headquarters in Pensacola, Florida, and operates a global support infrastructure with 24-hour critical support availability.

WatchRx is a digital healthcare platform built around smartwatch-enabled remote patient monitoring (RPM), chronic care management (CCM), transitional care management (TCM), and medication adherence solutions. The company provides an AI/ML-enabled cloud platform that integrates wearable technology to collect real-time patient vital signs and behavioral data, enabling clinicians to deliver proactive, value-based care and improve patient outcomes while reducing hospitalizations and urgent care visits. Primary markets include independent practices and primary care clinics, hospital systems, accountable care organizations (ACOs), and senior living and home care facilities. The platform automates clinical workflows, generates actionable insights for physicians, and supports medication adherence monitoring and GPS tracking for senior populations. Clinical evidence cited on the site demonstrates 76% reduction in hospitalizations, 51% reduction in urgent visits, and 90% patient satisfaction. The solution generates approximately $220+ additional revenue per patient per month through RPM/CCM billing codes. WatchRx partners with major healthcare networks and UnitedHealth Group. The company serves the growing market of value-based care delivery and remote monitoring, targeting reduction of healthcare costs and physician burnout while improving care coordination and patient engagement.

Healthcare MIT Services (HMS) is a medical technology company delivering AI-powered diagnostic imaging, intelligent patient monitoring, and connected care solutions. The company manufactures and distributes portable imaging systems, including low-dose fluoro-radiography and tabletop X-ray equipment designed for point-of-care, remote, and field deployment. Key product lines include contactless fall management and bedside monitoring systems utilizing AI-driven analysis without cameras or wearables; AI-enabled respiratory monitoring with noise-filtering capabilities; and clinical chemistry analyzers capable of running 16 tests in under 5 minutes with minimal blood samples (<90μL), ideal for remote and point-of-care settings. HMS also offers intelligent healthcare software solutions spanning smart ward and mobile nursing platforms, telehealth and remote care systems, and smart operating room integration. Medical supplies include certified PPE, mobile carts, and ready-to-deploy clinical kits. The company holds certifications including ISO 9001, ISO 13485, FDA clearance, EN 60601-1 medical device standard compliance, GMP, FCC, CUL, and CSA. HMS markets to hospitals, clinics, long-term care facilities, and field medical teams globally, with demonstrated presence at major medical conferences (HIMSS, RSNA, DMEA, AHCA/NCAL). The company emphasizes AI integration, radiation reduction, mobility, and safety across its product portfolio.

Zepp Health is a consumer health technology company delivering smart wearable healthcare solutions and digital health management platforms. The company manufactures intelligent wearables including smartwatches, smart bands, and smart hearing devices capable of continuous 24/7 health monitoring and biometric data collection. The Zepp Digital Health Management Platform integrates proprietary Zepp OS, AI chips, biometric sensors, and data algorithms to provide cloud-based actionable health insights and personalized wellness guidance. Key capabilities include real-time physiological monitoring, AI-driven sports and sleep coaching, atrial fibrillation detection (with 135,000+ suspected AFib events detected), and generative AI solutions utilizing Large Language Models for natural language interaction. The platform delivers preventative care insights and enables users to understand their health data for informed decision-making. Zepp Health serves a global consumer market with 42+ million active users across 90+ countries and has shipped over 200 million units worldwide. The company collaborates with 25+ world-class research partners and combines audiologist expertise with wearable technology for hearing solutions. Products feature proprietary sensors and algorithms optimized for continuous health tracking, fitness monitoring, sleep analysis, and wellness optimization across consumer segments.

Silex Global LLC is a healthcare and household products provider founded in 2014, operating across the United States, Canada, Mexico, and Europe. The company markets medical devices and wellness products under its Paramed brand, which specializes in both professional and domestic healthcare applications. Paramed's primary product lines include automatic and mechanical blood pressure monitors, digital and analog thermometers, and stethoscopes. All Paramed products are FDA-approved, CE-certified, and meet ISO standards. The company reports annual sales exceeding 100,000 blood pressure monitors, 10,000 thermometers, and 20,000 stethoscopes, serving more than 50,000 customers. Silex Global positions itself as a B2B supplier targeting distribution and retail companies seeking long-term partnerships. Products are designed for ease of use, portability, and advanced functionality, with independent testing and quality assurance prior to market release. The company emphasizes customer-centric service, rapid response times, and responsibility for product quality as core business values.

BKMed Store is a Brooklyn-based medical equipment and consumables supplier serving clinics, pharmacies, and healthcare professionals in the New York area. The company stocks a comprehensive range of surgical instruments, diagnostic tools, and disposable medical supplies. Product categories include surgical sutures, staplers and sealers, surgical trocars, catheters and guidewires, clips and appliers, orthopedic surgical consumables, and wound management supplies. The company also carries portable ultrasound machines, patient monitoring cables and sensors, respiratory circuits and filters, and orthopedic devices. BKMed Store partners with major manufacturers including Ethicon, Covidien, Stryker, Aesculap, BD, Philips, and Respironics. Services include fast local delivery to Brooklyn and surrounding areas, competitive bulk pricing for healthcare facilities, and direct support for professional procurement. The company operates as a B2B medical supplier focusing on consumables, replacement parts, and compatible accessories rather than primary diagnostic or surgical equipment.

Thermomedics, Inc. manufactures the CAREGIVER® Clinical Grade Non-Contact Infrared Thermometer (NCIT), a non-contact forehead thermometer developed by the team that invented tympanic thermometry. Introduced over 13 years ago, the CAREGIVER® has become the primary offering for hospitals, clinics, schools, and first-responder/rescue situations for measurement of forehead temperature in adults, children, and infants. The device delivers measurement results in 1–2 seconds with documented clinical precision and operates with AA battery power sufficient for up to 15,000 temperature measurements. Key features include non-contact infrared technology that eliminates probe covers and cross-contamination risk, bright backlit display with 30-temperature memory recall, one-button operation, and multi-task capability to measure room temperature and skin/surface temperature. The thermometer is rugged for routine hospital/clinical handling and is offered through major GPOs, IDNs, and supply chain leaders including VIZIENT, HPG, KAISER, NDC, McKesson, KentecAmerican, and a national network of regional healthcare dealers. Accessory offerings include wall-mount models, calibration verification systems, and secure tether models. The company supports clinical professionals with industry-leading customer service, product registration, and a comprehensive system of optional accessories for hospital/clinical management of efficient, safe, and accurate vital signs measurement.

NeurOptics is a worldwide leader in pupillometry technology for critical care, neurology, neurosurgery, emergency medicine, and applied research. The company develops and markets the NPi-300 Pupillometer, a handheld device that provides objective, quantitative assessment of pupil size and reactivity independent of examiner variability. The NPi-300 is adopted in over 1,000 U.S. hospitals and represented in more than 50 countries globally. The device measures pupillary responses and constriction velocity, enabling clinicians to detect subtle changes in pupillary response that may indicate increased intracranial pressure, neurological decline, or brain injury—particularly valuable in sedated or comatose patients where subjective penlight examination is unreliable. NeurOptics also provides pupillometry instrumentation for applied research applications, supporting both human and animal research across various clinical and research settings. The company emphasizes device integration with electronic medical records (EMR) to streamline clinical workflows and enable trend analysis of pupillary data as a vital sign. The NPi-300 is used extensively in neurocritical care units, stroke services, trauma centers, and cardiac arrest care settings. Clinical evidence supports the device in management of traumatic brain injury, cardiac arrest, malignant cerebral edema, and assessment for brain death determination.

Neko Health AB operates a preventive health screening service offering comprehensive full-body health assessments conducted at dedicated health centres. The company uses advanced multimodal scanning technology to capture measurements across body composition, blood vessels, heart rhythm, immune system markers, metabolism, and peripheral arteries, generating actionable health data within minutes. Clinical results are delivered immediately to patients with unrushed physician consultation included in the service. The company operates a doctor-led model of care emphasizing longitudinal health tracking and early disease detection through annual benchmark comparisons. Operating locations include four health centres in London (Covent Garden, Marylebone, Spitalfields, Victoria), one in Manchester (Lincoln Square), one in Birmingham (Colmore Row), and one in Stockholm (Östermalmstorg), with plans for expansion. Services are priced at £299 per scan. The organization collects aggregated health data for research purposes and maintains a membership model. Neko Health focuses on preventive medicine and wellness monitoring for health-conscious individuals seeking proactive health management rather than reactive clinical intervention.

Thinklabs Medical manufactures digital stethoscopes designed for clinical auscultation and telemedicine integration. The company's flagship product, the Thinklabs One Digital Stethoscope, features 100x audio amplification with five precision filter options, enabling clinicians to isolate and enhance cardiac, pulmonary, and other body sounds. The device includes rechargeable battery technology (100–120 patient exams per charge), Bluetooth and wired connectivity to most headphones and telemedicine platforms, and integrates seamlessly with major EHR and telemedicine software including Zoom, Cisco WebEx, Teladoc, American Well, and other systems without requiring screen switching during patient consultation. The stethoscope is used across 50+ countries and seven continents in primary care, cardiology, pulmonology, nursing, education, critical care, emergency medicine, pediatrics, NICU, anesthesiology, hospice, research, veterinary, and government/military settings. Marketed as a device for both clinical diagnostics and enhanced hearing accessibility for audiologists and hard-of-hearing practitioners, Thinklabs stethoscopes are employed in hospitals, FQHCs, acute care facilities, clinical trials, school-based health programs, and workplace health initiatives. The company emphasizes precision audio engineering and clinical utility without proprietary ecosystems, enabling broad deployment across institutional and private practice settings.

Bell Medical, Inc. is a specialized distributor and service provider of anesthesia equipment, supplies, and biomed services established in 1975. The company operates as an exclusive distributor for major anesthesia manufacturers including Armstrong Medical, Amsorb Plus CO2 Absorbent, Heine, Propper, Rusch, Sunmed, Upsher, and others. Product portfolio encompasses anesthesia machines (GE Healthcare, Drager, Penlon, Datascope, Mindray, Ohmeda legacy models), laryngoscopes and blades, endotracheal tubes (Parker Flex-Tip), nerve stimulators with train-of-four monitoring (Stimpod 450X+ with AMG/EMG capabilities), supraglottic airways (AES brand), spinal needles (IMD Gertie Marx), oxygen sensors (Ceramatec, Analytical), temperature indicators (Clinitemp), ultrasound probe covers (Safersonic), and difficult airway management systems (Insight System, Eschmann Stylet). Bell Medical provides preventive and emergency service and maintenance for anesthesia machines, parts supply, and general biomedical services across Illinois to Utah. The Stimpod 450X+ represents their flagship neuromuscular monitoring product, featuring dual AMG/EMG technology for cost-effective blockade monitoring at point-of-care. Company also stocks medical carts (MPD brand), cardiopulmonary monitors (Schiller, Criticare), and addresses emerging clinical needs such as subglottic endotracheal tubes (NEVAP) for aspiration prevention in GLP-1 agonist users.

Werfen is a global in vitro diagnostics company operating directly in over 30 countries and through distributors in more than 100 territories. The company develops, manufactures, and commercializes diagnostic systems, reagents, software, and services across hemostasis, acute care diagnostics, transfusion, autoimmunity, transplant, immunoassay, and clinical chemistry. Werfen's hemostasis portfolio includes in vitro diagnostic systems and reagents for diagnosing and guiding treatment of thrombotic and bleeding disorders. The acute care diagnostics line provides integrated whole-blood testing solutions for cardiovascular operating rooms, catheterization laboratories, intensive care units, and emergency departments. The transfusion division offers manual and automated solutions with serology reagents, fully automated instrumentation, data management software, and molecular products for donor-recipient compatibility. The autoimmunity segment delivers reagents and lab automation for diagnosing and monitoring autoimmune diseases. Transplant products feature molecular and antibody-based HLA assays and software for pretransplant compatibility determination and post-transplant monitoring. Clinical chemistry solutions serve chemistry and pharma-toxicology laboratories. Werfen also recently completed the acquisition of Omixon, a Budapest-based company specializing in next-generation sequencing technologies for transplant diagnostics. The company maintains a technology center in Bedford, Massachusetts, expanded in December 2024. Werfen's solutions are designed to improve patient care quality, reduce laboratory costs, ensure regulatory compliance, and enhance operational efficiency across clinical laboratory and acute care hospital settings.

FIGUR8, Inc. develops FDA-registered musculoskeletal (MSK) assessment technology that replaces subjective measurement tools with objective, lab-grade biomechanics data. The company's flagship platform, the bioMotion Assessment Platform (bMAP), combines on-body wearable sensors with cloud-based analytics to provide precise movement analysis and functional capacity assessments. FIGUR8 serves physical therapists, orthopedic surgeons, chiropractors, occupational health clinics, workers' compensation payers, and sports medicine practitioners. The platform captures over one million data points during dynamic functional movement testing, offering quantitative metrics for injury assessment, recovery monitoring, and return-to-work determination. Use cases include workers' compensation claim management, surgical candidacy evaluation, post-injury rehabilitation tracking, and athletic performance assessment. FIGUR8 is particularly positioned for workers' compensation and occupational health markets, where objective MSK data reduces claim duration and improves outcomes. The company emphasizes clinical training and provider enablement through didactic courses and onsite support. Regulatory status includes FDA registration; the site references compliance with clinical standards and the APTA Digital Transparency Pledge. The technology addresses a significant clinical gap by providing consistent, repeatable objective metrics superior to manual muscle testing and traditional subjective clinical assessments.

Aidar Health designs and develops clinically validated digital medicine software platforms and breath- and saliva-based biosensors for precision disease management across therapeutic areas including respiratory, renal, infectious, cardiovascular, and oncology. The company operates three primary product lines: Aidar Connect (clinician web application for remote patient monitoring and care coordination), MouthLab (medical device for biosensor data collection), and Aidar Care (patient mobile application). Aidar serves multiple market segments through specialized service offerings: Long-Term Care (remote physiological monitoring, chronic care management, transitional care management, hospital-at-home programs); Life Sciences (digital biomarkers, digital companions, decentralized clinical trials, real-world evidence collection); and Population Health Management for payers. The platform enables objective, non-invasive assessment of clinical status, facilitates early disease detection, supports treatment optimization, and enables risk stratification to reduce readmissions and emergency department utilization. Aidar has received FDA clearance for its breath-based medical device and maintains partnerships with major research institutions (NIH, Johns Hopkins, VA) and government agencies (BARDA, NSF). The company targets clinical outcomes improvement and cost reduction through digital-first precision medicine approaches suitable for aging populations and chronic disease management.